Dimethyldioctylammonium bromide
Dimethyldioctylammonium bromide has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Apr 7, 2026: “Quaternary Ammonium Compound Induced Electrocardiogram Abnormalities with Body Fat as a Potential Effect Modifier: A Longitudinal Multiomics Panel Study in Elderly Adults”.
1 paper studies it1 findingUpdated
See all 1 papers on dimethyldioctylammonium bromide
At a glance
The findings reach people, from one lab or study. 1 lab in 2 countries.
“C8-DDAC was related to increased QT interval, QTc interval, and RV5/SV1 amplitude, as well as a reduced QRS time”
Humans: a single group. Cells, worms or flies and mice: nothing yet.
- 1 lab in 2 countries
- Funders: National Key Research and Development Program of China and 1 more
- Humans1
What is dimethyldioctylammonium bromide linked with?
1Studies link dimethyldioctylammonium bromide with corrected QT interval.
Corrected QT interval
upin humans1
1 study
Corrected QT interval
upin humans1
Dimethyldioctylammonium bromide is associated with corrected QT interval in humans.
“C8-DDAC was related to increased QT interval, QTc interval, and RV5/SV1 amplitude, as well as a reduced QRS time”
Humansheartfive-monthn = 76
Environmental science & technology
Latest
1 paper in 12 monthsEnvironmental Science & Technology
Quaternary Ammonium Compound Induced Electrocardiogram Abnormalities with Body Fat as a Potential Effect Modifier: A Longitudinal Multiomics Panel Study in Elderly Adults
Cohort study of 76 peoplePopulations